Amneal reports certain preliminary second quarter 2025 financial results

– results reflect continued financial strength and deleveraging – bridgewater, n.j., july 21, 2025 (globe newswire) -- amneal pharmaceuticals, inc. (nasdaq: amrx) (“amneal” or the “company”) today announced certain unaudited preliminary financial results for the second quarter ended june 30, 2025.
AMRX Ratings Summary
AMRX Quant Ranking